THE SAINSBURY LABORATORY

Their core work

The Sainsbury Laboratory is a world-class plant science research centre in Norwich, UK, focused on understanding how plants defend themselves against diseases. Their core work involves decoding the molecular mechanisms of plant immune receptors — the proteins that detect and respond to pathogen attacks. They engineer disease resistance in crops, including work on banana Panama disease and blast fungi in cereals, combining fundamental immunology with genome editing tools like CRISPR. Their research directly addresses global food security by developing strategies to protect staple crops from devastating pathogens.

What they specialise in

How they've shifted over time

In the early period (2015–2018), TSL's work spanned broadly across fundamental plant-microbe interactions — cell death signalling, transcriptional regulation, CRISPR-based resistance engineering in banana, and proteomics-driven mechanistic studies. From 2017 onward, the focus sharpened toward immune receptor biology specifically: NLR receptor diversification, transfer between species, and high-throughput discovery of virulence and resistance mechanisms (TurboID-based approaches). The trajectory shows a lab moving from broad plant immunity questions toward precision tools for decoding and redesigning immune receptor networks.

TSL is converging on rapid, technology-driven discovery of immune receptor functions, positioning them to design transferable disease resistance across crop species.

How they like to work

TSL operates almost exclusively as a project coordinator (10 of 11 projects), overwhelmingly through individual Marie Curie fellowships and ERC grants rather than large consortia. With only 2 unique consortium partners across all projects and collaboration limited to 1 country, they function as an elite host lab that attracts top postdoctoral researchers rather than as a consortium-building hub. Working with TSL means engaging a focused, independent research powerhouse — expect them to lead or host, not to slot into a supporting role.

TSL has a remarkably small formal H2020 network — just 2 unique partners in 1 country — because their funding model relies on individual fellowships (MSCA) and PI grants (ERC) rather than multi-partner consortia. Their real network influence comes through hosting international researchers, not through consortium partnerships.

What sets them apart

TSL is one of a handful of labs globally that combines deep fundamental knowledge of plant NLR immune receptors with the ambition to redesign them for crop protection. Their concentration of MSCA and ERC grants (the most competitive individual funding schemes) signals exceptional scientific quality — these grants are won on reputation and track record, not consortium politics. For anyone needing a partner in plant immunity or disease resistance, TSL brings a depth of molecular expertise that few institutions can match.

Highlights from their portfolio

• ImmunityByPairDesign
  Largest single grant (EUR 1.97M ERC Advanced Grant) — designing and redesigning plant immune receptor complexes, representing TSL's flagship research line.
• BLASTOFF
  Second-largest grant (EUR 1.87M ERC Starting Grant) tackling blast fungi resistance, signalling TSL's expansion from model plants to major cereal crop threats.
• BIO-Banana IN and OUT
  Applies CRISPR genome editing to engineer Panama disease resistance in banana — the most directly translational and commercially relevant project in TSL's portfolio.